Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (HK:6990) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is moving forward with full circulation of its H shares, representing 0.52% of the company’s total share capital, pending necessary approvals and regulatory procedures. This strategic maneuver aims to enhance the liquidity of shares and is in line with guidelines set by the China Securities Regulatory Commission. Investors are advised to be cautious and stay tuned for further announcements regarding the progress of this initiative.
For further insights into HK:6990 stock, check out TipRanks’ Stock Analysis page.